Pneumococcal vaccination and revaccination of older adults. - Wikidata - awgldk - TriplyDB

Pneumococcal vaccination and revaccination of older adults.

Pneumococcal vaccination and revaccination of older adults.

http://www.wikidata.org/entity/Q34926870

about

Prospects for developing an effective particle-mediated DNA vaccine against influenza.Depletion of complement has distinct effects on the primary and secondary antibody responses to a conjugate of pneumococcal serotype 14 capsular polysaccharide and a T-cell-dependent protein carrier.Prevention strategies for herpes zoster and post-herpetic neuralgia Proprietary arabinogalactan extract increases antibody response to the pneumonia vaccine: a randomized, double-blind, placebo-controlled, pilot study in healthy volunteers Randomized, single blind, controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in renal transplant recipients.Revisiting the B-cell compartment in mouse and humans: more than one B-cell subset exists in the marginal zone and beyond.Subversion of the B-cell compartment during parasitic, bacterial, and viral infections Pneumococcal capsular polysaccharide vaccine-mediated protection against serotype 3 Streptococcus pneumoniae in immunodeficient mice.Immune Responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination.Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept.Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines.Alterations in marginal zone macrophages and marginal zone B cells in old mice Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: a systematic review.Recommendations for the use of the 23-valent polysaccharide pneumococcal vaccine in adults: a Belgian consensus report.Proteomic contributions to our understanding of vaccine and immune responses.Revaccination of adults with spinal cord injury using the 23-valent pneumococcal polysaccharide vaccine.Antibody response to pneumococcal vaccination as a function of preimmunization titer.Biology of immune responses to vaccines in elderly persons.Safety and immunogenicity of a single dose 23-valent pneumococcal polysaccharide vaccine in Russian subjects.Overview of vaccination policies for the elderly in Western European countries.Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe.Pneumococcal vaccination among adults with chronic respiratory diseases: a historical overview.Preventing pneumococcal disease in the elderly: recent advances in vaccines and implications for clinical practice.Vaccination in the elderly: what can be recommended?Vaccines: A review of immune-based interventions to prevent and treat disease.BAFF receptor and TACI in B-1b cell maintenance and antibacterial responses.Evaluating the costs and benefits of pneumococcal vaccination in adults.Effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive disease and hospital-treated pneumonia among people aged ≥65 years: a retrospective case-control study.An explosive outbreak of Streptococcus pneumoniae serotype-8 infection in a highly vaccinated residential care home, England, summer 2012.Age-Related Changes in Human Peripheral Blood IGH Repertoire Following Vaccination.Host-pathogen interaction during pneumococcal infection in patients with chronic obstructive pulmonary disease.Invasive pneumococcal infections in adult lung transplant recipients.Assignment of weight-based immunoglobulin G1 (IgG1) and IgG2 units in antipneumococcal reference serum lot 89-S(F) for pneumococcal polysaccharide serotypes 1, 4, 5, 7F, 9V, and 18C A 21-winter seasons retrospective study of antibody response after influenza vaccination in elderly (60-85 years old) and very elderly (>85 years old) institutionalized subjects.V(H)3 antibody response to immunization with pneumococcal polysaccharide vaccine in middle-aged and elderly persons.Public vaccination policy using an age-structured model of pneumococcal infection dynamics.Vaccination of older persons: a broader perspective.Adjuvant Probiotics and the Intestinal Microbiome: Enhancing Vaccines and Immunotherapy Outcomes.Pneumococcal vaccination and chronic respiratory diseases.Lifelong Maintenance of Oral Tolerance and Immunity Profiles in Mice Depends on Early Exposure to Antigen.

P2860

Q30380300-7D601908-1DE1-486E-A3AE-05D2D0CC4305 Q33558995-0E640A77-F01A-48B5-9A7C-0D6E9AC29B61 Q33562809-F10284A3-213B-407F-AE1A-A4169B305609 Q34128683-80CE3A36-D264-4713-AEFA-D0A82BC4E8D8 Q34430844-75DF8248-0068-41E5-ACFD-4F7B86E6BD17 Q34495557-6A7120B6-96FA-40C0-8613-D89D1DECC52E Q35218945-0B77C1AC-35C8-4ABA-9956-686239E26522 Q35783722-41C3FBAD-12F7-4090-9D1D-334D2661C235 Q35874108-23D50DAF-3C16-4870-8B2E-BC8FE707EB6E Q36031285-AFEB0E82-CFA8-436E-9D7A-C135C702CFFD Q36083360-258F17B6-8978-4D93-890D-513653066132 Q36168169-3A86BEC1-4F08-425B-842C-33E47F06F11B Q36204195-AE186FE2-A0B6-4181-98C0-0B1E792B65E9 Q36406774-AD73B641-5D76-4F16-965D-7F213463A87D Q36464016-A2868651-DC18-4B2E-9B84-D57B002CF288 Q36731011-5838C234-C270-426B-805E-32BD269B0246 Q36731708-8F9FA5AF-1711-4956-B105-661F49D64AE7 Q37150299-7CC2E358-9DD3-4313-B793-AF39EBD71403 Q37197130-DBC946F1-3A62-47B7-AABD-BFAD7ED6EF31 Q37538372-114119BF-A60B-40B8-B753-0EBFC5E9A065 Q37910264-B2B8F701-B373-4B09-884A-8AC6B2A20196 Q37981768-A5618106-76A0-4248-B857-6F7B0266DD78 Q38082673-E0D238B1-AC5C-4B6F-B7CD-FB924618A306 Q38220158-9FF26F85-CEF0-43DF-91CE-2576F6E123C1 Q38364468-AB032056-8752-410C-BA6B-BDD64B00494A Q38472786-3F2B6805-5F60-477A-B7AC-CAF9F9C8FE49 Q38966828-191BAC22-9AB2-493C-A25F-C23F20E6FA87 Q39041235-556EC042-C2F7-47FF-B182-A03E9D549E55 Q39116534-B1304197-0881-4A9F-8C14-49FEB1C6C063 Q39587551-2EA0A25C-9D7C-4B34-8326-9B26A2C26306 Q40469947-F0CBBBDA-C936-4626-90BC-8270E2DB229D Q40494158-898179CF-B49F-4B19-85F8-AE1D0168068B Q40773230-394A6393-43FF-408C-8F51-46342D560ED2 Q41935331-C57ECFEB-C0C1-4E4A-BC2D-375D185BD86C Q42706531-B574FFEE-AB64-49CD-9BF2-A264AF6FDBF3 Q44865385-831F911A-9F4F-49EA-A52F-0BD3609EC067 Q46651028-C04BFD95-5788-4A53-96B4-4ED7EA6D3051 Q47159439-DDCF2185-26BB-4288-866C-2804B6A9DAFD Q47162758-1EDA3772-E111-45F3-AE60-F5A57022217A Q48202683-7EF75F62-4A9E-43E1-A96A-95036C4E695A

P2860

Pneumococcal vaccination and revaccination of older adults.

http://www.wikidata.org/entity/Q34926870

description

2003 nî lūn-bûn

@nan

2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Pneumococcal vaccination and revaccination of older adults.

@ast

Pneumococcal vaccination and revaccination of older adults.

@en

Pneumococcal vaccination and revaccination of older adults.

@nl

type

label

Pneumococcal vaccination and revaccination of older adults.

@ast

Pneumococcal vaccination and revaccination of older adults.

@en

Pneumococcal vaccination and revaccination of older adults.

@nl

prefLabel

Pneumococcal vaccination and revaccination of older adults.

@ast

Pneumococcal vaccination and revaccination of older adults.

@en

Pneumococcal vaccination and revaccination of older adults.

@nl

P1433

Q34926870-8107C751-C7E2-48DB-91F7-386D7FB533F6

P1476

Q34926870-81E30B99-322D-4D20-808E-1522C043D42C

P2093

Q34926870-32DC9892-FB04-4BEC-AC98-46E13C755647

Q34926870-C28DC893-679E-441A-BAF3-0EA898C6D3C0

Q34926870-D9150310-D4C4-44DA-87F3-A5792D3E8145

P2860

Q34926870-038E2468-243A-4E56-AEF4-C90CFA62D549

Q34926870-0BC6F1B6-5993-42A7-9BC5-80362FF8B55A

Q34926870-0CB475AF-B37A-4E03-9509-83169B4B050E

Q34926870-1218A9D3-0C99-4C7E-A1B1-0F35F77C3FDD

Q34926870-12321F13-7146-469A-B603-C19690FDE604

Q34926870-15634276-A1E3-48A1-8624-0E26FA8E10E5

Q34926870-16CF2B6E-5346-4286-B34C-49E4E67C9A7C

Q34926870-17490352-6252-4412-8D81-CC32B7B11E60

Q34926870-1A522C1E-2866-4B9C-BFDB-48FFE33A6777

Q34926870-1D489D71-2857-413A-90A1-8C5DA4797D12

P304

Q34926870-844375A2-1E36-4763-922B-DA849B79F6BF

P31

Q34926870-1D4A3CE6-50EB-49F7-9EF5-4437D0E2484A

P356

Q34926870-EB12C8DB-39FB-4D95-820D-D5EFCD71B4E9

P407

Q34926870-972286B8-86C5-4D3C-B306-3F9C16F5D2C8

P433

Q34926870-E6EEBC3C-D049-4DBB-BCC5-18680D6DE313

P478

Q34926870-3AA8E73B-8E15-4BCE-8EAF-978259DCB155

P577

Q34926870-756D6505-9A3A-4902-9126-A2F522B7DB44

P698

Q34926870-490A958D-B443-4530-B476-2657F9012144

P932

Q34926870-0BD7D8E7-CED7-4CE6-849B-0ACD77973C5D

P356

CMR.16.2.308-318.2003

P1433

Clinical Microbiology Reviews

P1476

Pneumococcal vaccination and revaccination of older adults.

@en

P2093

Andrew S Artz

http://www.w3.org/2001/XMLSchema#string

Dan L Longo

http://www.w3.org/2001/XMLSchema#string

William B Ershler

http://www.w3.org/2001/XMLSchema#string

P2860

Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials

Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team

Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations

Thymus-Independent and Thymus-Dependent Responses to Polysaccharide Antigens

Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study.

Antibody to capsular polysaccharide of Streptococcus pneumoniae at the time of hospital admission for Pneumococcal pneumonia.

The putative proteinase maturation protein A of Streptococcus pneumoniae is a conserved surface protein with potential to elicit protective immune responses

Pneumococcal vaccines: history, current status, and future directions.

The clinical effectiveness of pneumococcal vaccination: a brief review.

Pneumococcal pneumonia: epidemiology and clinical features.

P304

308-318

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/CMR.16.2.308-318.2003

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2003-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12692100

http://www.w3.org/2001/XMLSchema#string

P932

153142

http://www.w3.org/2001/XMLSchema#string